ProKidney News

Buy Rating Affirmed for ProKidney Amidst Strategic Clinical Advancements and Solid Financial Outlook

TipRanksMar 23 22:36

ProKidney Analyst Ratings

BenzingaMar 7 17:20

Analysts Conflicted on These Healthcare Names: ProKidney (PROK), Gritstone Oncology (GRTS) and MicroPort Scientific (OtherMCRPF)

TipRanksMar 6 19:20

BTIG Reaffirms Their Buy Rating on ProKidney (PROK)

TipRanksJan 2 22:32

B of A Securities Downgrades ProKidney to Neutral, Lowers Price Target to $2

BenzingaJan 2 22:08

ProKidney Analyst Ratings

BenzingaJan 2 22:05

Analysts Offer Insights on Healthcare Companies: Urogen Pharma (URGN), Palatin Technologies (PTN) and ProKidney (PROK)

TipRanksNov 15, 2023 20:31

ProKidney's Future Promising: REACT Trial Success and Strategic Enrollment Shift Boosts Buy Rating

TipRanksNov 15, 2023 19:23

BTIG Initiates Coverage On ProKidney With Buy Rating, Announces Price Target of $16

BenzingaJul 25, 2023 16:32

ProKidney Analyst Ratings

BenzingaJul 25, 2023 16:31

Analysts Offer Insights on Healthcare Companies: ProKidney (PROK) and Enliven Therapeutics (ELVN)

TipRanksMay 12, 2023 20:10

Jefferies Initiates Coverage On ProKidney With Buy Rating, Announces Price Target of $15

Benzinga Real-time NewsDec 21, 2022 19:21

Morgan Stanley Initiates Coverage On ProKidney With Equal-Weight Rating, Announces Price Target of $13

Benzinga Real-time NewsNov 10, 2022 21:01